Sulforaphane Reduces the Chronic Inflammatory Immune Response of Human Dendritic Cells

• Published in: Nutrients Vol. 15; no. 15; p. 3405
• Main Authors: Fernandez-Prades, Laura, Brasal-Prieto, Mariano, Alba, Gonzalo, Martin, Victoria, Montserrat-de la Paz, Sergio, Cejudo-Guillen, Marta, Santa-Maria, Consuelo, Dakhaoui, Hala, Granados, Beatriz, Sobrino, Francisco, Palomares, Francisca, Lopez-Enriquez, Soledad
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 31.07.2023; MDPI
• Subjects: antioxidants; Apoptosis; Autophagy; B cells; Cancer; Cell Differentiation; cell lines; Cells, Cultured; Cytokines; Cytokines - metabolism; Dendritic Cells; Flow cytometry; Functional foods & nutraceuticals; Humans; Immune response; Immunity; Inflammation; Inflammation - drug therapy; Inflammation - metabolism; interleukin-10; interleukin-13; interleukin-9; Isothiocyanates - metabolism; Isothiocyanates - pharmacology; Kinases; lipopolysaccharides; lymphocyte proliferation; Lymphocytes; Monocytes - metabolism; neoplasm cells; Software; sulforaphane; vegetables; Spain; United States > US; Germany; T lymphocytes; apoptosis; autophagy; dendritic cells; anti-inflammatory response; nutraceutical
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15153405

Background: Sulforaphane (SFN) is an isothiocyanate of vegetable origin with potent antioxidant and immunomodulatory properties. The characterization of its pleiotropic activity in human dendritic cells (DCs) is poorly summarized. The aim of this work was to study the immunomodulatory power of SFN in response to an inflammatory microenvironment on human monocyte-derived DCs (moDCs). Methods: We studied the immunological response induced by SFN. Apoptosis and autophagy assays were performed using flow cytometry on moDCs and a cancer cell line (THP-1). These included moDC maturation, lymphocyte proliferation and cytokine production under different experimental conditions. We investigated whether these results were associated with an inflammatory microenvironment induced by lipopolysaccharides (LPSs). Results: Our results demonstrated that SFN could interact with moDCs, significantly reducing the autophagy process and enhancing apoptosis similarly to cancer cell line THP-1 cells in a chronic inflammatory microenvironment. Under chronic inflammation, SFN modulated the phenotypical characteristics of moDCs, reducing the expression of all markers (CD80, CD83, CD86, HLA-DR and PD-L1). SFN significantly reduced the Th2 proliferative response, with a decrease in the IL-9 and IL-13 levels. Although we did not observe any changes in the regulatory proliferative response, we noted an increase in the IL-10 levels. Conclusions: These findings demonstrate that SFN exerts protective effects against LPS-induced inflammation via the modulation of moDCs/T cells towards a regulatory profile. SFN may be a potential candidate for the treatment of pathologies with an inflammatory profile.